Skip to main content

Table 3 The median serum SAA, CA125 and HE4 concentration

From: Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression

Group

N

SAA [mg/L,M (QR)]

CA125 [U/L, M (QR)]

HE4 [pmol/L,M (QR)]

Health

30

4.95 (3.27–7.67)

17.79 (10.48–30.77)

21.39 (14.38–30.71)

Benign disease

36

6.10 (4.70–9.45)

35.86 (15.82–53.16)

47.73 (37.39–74.64)

Ovarian cancer

36

32.30 (11.20–119.6)

640.00 (251.65–1218.50)

259.5 (125.00-

736.00)